摘要
家族性高胆固醇血症(FH)是一种常染色体显性遗传病,临床表现为血浆总胆固醇和低密度脂蛋白胆固醇水平升高、皮肤或肌腱黄色瘤和早发冠心病。FH的治疗手段主要包括临床治疗和基因治疗,近年来新药的研发和基因研究的快速发展为FH的治疗提供了更多的手段,本文将对FH的临床和基因治疗的新进展进行综述。
Familial hypercholesterolemia is an autosomally dominant disease and clinically characterized by elevated serum levels of total and low density lipoprotein cholesterol, the presence of tendon xanthomas and premature coronary ar- tery disease. Clinical and genetic therapies are .the main treatments of familial hypercholesterolemia. Several drugs and genetic research are emerging to help improve the treatments of this disease in recent years. In this review, we will pres- ent the recent developments in the clinical and genetic treatments of familial hypercholesterolemia.
出处
《中国动脉硬化杂志》
CAS
CSCD
北大核心
2014年第12期1287-1291,共5页
Chinese Journal of Arteriosclerosis
关键词
家族性高胆固醇血症
临床治疗
基因治疗
Familial Hypercholesterolemia
Clinical Therapy
Genetic Therapy